TG Therapeutics, Inc. to Host Conference Call on Third Quarter 2016 Financial Results and Business Update

Go back to TG Therapeutics, Inc. to Host Conference Call on Third Quarter 2016 Financial Results and Business Update

TG Therapeutics (TGTX) Misses Q3 EPS by 19c

November 7, 2016 7:34 AM EST

TG Therapeutics (NASDAQ: TGTX) reported Q3 EPS of ($0.50), $0.19 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $38.1 thousand versus the consensus estimate of $30 thousand.

Cash, cash equivalents, investment securities, and interest receivable were $60.7 million as of September 30, 2016.

For... More